Study of Predictors of Clinical Outcomes in Patients With HR+ and HER2-low/Negative Breast Cancer
Conditions: Hormone-receptor-positive Breast Cancer; HER2-low Breast Cancer; HER2-negative Breast Cancer Intervention: Other: No drug Sponsor: Daiichi Sankyo, Inc. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2023 Category: Research Source Type: clinical trials
The Efficacy and Safety of PEGylated GH for the Treatment of Short Stature in Chinese Children-GLOBE Reg
Conditions: Growth Hormone Treatment; Growth Disorders Intervention: Drug: Polyethylene glycol recombinant human growth hormone injection Sponsors: Beijing Children's Hospital; Office for Rare Conditions Registries, University of Glasgow Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2023 Category: Research Source Type: clinical trials
